Gross sales up 10.1% YoY to Rs 10,644 cr; EBITDA at Rs 2,884.4 cr, with a margin of 26.8%
All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody
Glenmark Pharmaceuticals on Thursday said it has launched a novel fixed-dose combination (FDC) drug in the country for patients with uncontrolled asthma. The Mumbai-based drug major has launched - Indacaterol + Mometasone FDC under the brand name Indamet. The drug will be available in three strengths with a fixed dose of Indacaterol 150 mcg and variable doses of Mometasone 80 mcg, 160 mcg and 320 mcg to be taken once daily. "Respiratory is a key focus area for Glenmark, and the company leads from the front in providing access to the latest treatment options to patients. "We are proud to introduce this novel fixed-dose combination Indamet, which is the first of its kind in India, offering an affordable treatment option to both adults and adolescents 12 years of age and older suffering from uncontrolled asthma," Glenmark Pharmaceuticals Group Vice President & Head (India Formulations) Alok Malik said in a statement. The drug maker is the first company in India to market the FDC of .
Pfizer has announced it is to supply all its current and future patent-protected medicines and vaccines on a not-for-profit basis to 45 lower-income countries and is talking to other big drugmakers
The Chief Minister held a review meeting in this regard with Chief Secretary
Deaths due to drug overdose have topped a million over past 20 years, U.S. broadcaster NPR reported on Thursday, citing statistics from the Centers for Disease Control and Prevention (CDC)
Committee will frame draft Bill and submit it by November 30
: Researchers at Indian Institute of Technology, Hyderabad, have developed an oral solution to treat Black Fungus (Mucormycosis) and other fungus and are ready to transfer the technology to take it forward, the premier institute said.
The Delhi High Court has directed online search engine Google to remove links to a judgement acquitting an Indian origin American citizen of drug charges
The study, published in the journal Annals of the Rheumatic Diseases, linked treatment of RA with improvements in vascular stiffness -- an indicator of CVD
A drug used to cure a deadly viral disease in cats may be effective as a treatment for humans against coronavirus, according to a study that may lead to new therapeutics to treat Covid-19
Trying to boost acquired Wockhardt portfolio which saw sharp decline in sales during pandemic
The company said the drug is cheaper than alternatives and would be supplied to Cipla for the launch of Ciplenza, the generic version of Favipiravir
The reasons behind recall could vary from contamination (cross-batch, air-borne, dosage mix up, container, impurities) to wrong labelling, discolouration of tablets, non-standard quality
The finding was based on a brain scan data set of 144 European adolescents
The United States will account for up to $675 billion of the $1.5 trillion
Cadila Healthcare Q2 standalone Net dips 82%; consolidated net down 29%
The raids were carried out last week at the premises of Dolphin Pharama in Vadodara and at KC Pharma in Andheri in Mumbai
Indian companies grew 10.9% during July, while MNC pharma companies by 5% with Sanofi leading the pack with 20.6%
Similar were the magnitude shown by people who had experienced sexual abuse in their childhood